advertisement
14 Costing studies; pharmacoeconomics (3)
Showing records 1 to 3
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics9882 Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers
Houde M; Castilloux AM; Tingey D; Assalian A; LeLorier J
Canadian Journal of Ophthalmology 2003; 38: 469-475
9904 Assessing the cost-effectiveness of switching from a β-blocker to latanoprost in the treatment of ocular hypertension
Costagliola C; Parmeggiani F; Sebastiani A
Expert Opinion in Pharmacotherapy 2003; 4: 1775-1788
10023 Cost of glaucoma in Canada: analyses based on visual field and physician's assessment
Iskedjian M; Walker J; Vicente C; Trope GE; Buys Y; Einarson TR; Covert D
Journal of Glaucoma 2003; 12: 456-462
